Lenalidomide delays progression of smouldering multiple myeloma

Treatment, rather than observation, is now appropriate, say researchers

Early treatment with lenalidomide significantly delays the progression of smouldering multiple myeloma to symptomatic disease, according to the results of a randomised trial.